Valencia Nutrition Limited reported a consolidated total revenue of ₹957.84 lakh and a net profit of ₹109.27 lakh for the financial year ended March 31, 2026. The company's Board of Directors approved the audited standalone and consolidated financial results for the half-year and full year in a meeting held on May 28, 2026. The statutory auditors, M/s. H A Y & Associates LLP, issued an unmodified opinion on these results.

The Board also approved the re-appointment of M/s. SPDS & Associates LLP as the Internal Auditor for a tenure of three years, effective from the conclusion of FY 2025-26 up to the end of FY 2028-29. Additionally, the Board addressed a notice of non-compliance from the exchange, confirming that systemic rectifications have been completed and the applicable penalty has been fully paid.

Financial Performance

The consolidated financial results for the year ended March 31, 2026, showed a decrease in revenue from operations compared to the previous year. The company reported a total revenue of ₹957.84 lakh for FY26, down from ₹912.01 lakh in FY25. Net profit for the period stood at ₹109.27 lakh.

Operational Updates

The company provided updates on its subsidiaries and business verticals. Valencia Beverages & Superwater Private Limited, a wholly-owned subsidiary, commissioned two manufacturing units and secured a co-packing agreement with Virchow Laboratories Limited. Valencia Nutraceutical Lifesciences Private Limited, a 75% holding subsidiary, is entering commercial production with formulations validated across pregnancy and lactation nutrition verticals.

The company also commenced pilot production of fortified Valencia Osmania Biscuits in March 2026 under the brand 'Valencia Bakery'. This follows the earlier strategic move to enter the packaged bakery segment with an estimated investment of ₹4 crore over two years. The Point of Sales for beverages, snacks, and biscuits are common, ensuring supply chain efficiency.

valencia nutrition has scheduled a meeting of its Board of Directors for Thursday, May 28, 2026. The meeting will be held at 12:30 p.m. IST to discuss and approve key financial agenda items.

Agenda for the Meeting

The primary purpose of the meeting is to consider and approve the Audited Standalone and Consolidated Financial Results of the Company. These results pertain to the half-year and financial year ended March 31, 2026. The approval will include the Report of the Statutory Auditor, as recommended by the Audit Committee.

Trading Window Closure

In compliance with the Company's Code of Conduct for the prevention of Insider Trading and the SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in the securities of the Company will remain closed. This closure is effective from the end of the half-year and financial year ended March 31, 2026, and will continue until 48 hours after the declaration of the Audited Standalone and Consolidated Financial Results.

The restriction applies to all Directors, designated employees, connected persons, auditors, consultants, and their immediate relatives.

Key Meeting Details